|Venture Round, 1/2010 ||$43M|
|Venture Round, 5/2013 |
Oracle Investment Management Inc.
|Venture Round, 12/2013 ||$17.6M|
We will develop and commercialize high-value, multi-marker, diagnostic tests which address unmet needs in gynecologic oncology and women’s health. We will accomplish our mission through internal development, targeted acquisitions, and collaborations with leading scientific and clinical institutions. Our global commercial efforts will include direct marketing and sales activities as well as partnerships with leading companies in women’s health.